BSE Live
Nov 21, 16:01Prev. Close
2512.90
Open Price
2504.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 21, 15:46Prev. Close
2510.70
Open Price
2497.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2485.70 (4)
| Key Financial Ratios of Ajanta Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 73.56 | 64.82 | 45.89 | 82.45 | 75.09 | |
| Diluted EPS (Rs.) | 73.53 | 64.77 | 45.89 | 82.45 | 75.09 | |
| Cash EPS (Rs.) | 84.92 | 75.31 | 56.89 | 97.61 | 88.55 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 302.38 | 282.34 | 268.14 | 380.24 | 344.52 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 302.38 | 282.34 | 268.14 | 380.24 | 344.52 | |
| Revenue from Operations/Share (Rs.) | 370.81 | 333.10 | 296.21 | 389.17 | 332.34 | |
| PBDIT/Share (Rs.) | 108.02 | 99.45 | 69.80 | 121.72 | 117.83 | |
| PBIT/Share (Rs.) | 96.52 | 88.73 | 59.45 | 107.13 | 104.48 | |
| PBT/Share (Rs.) | 94.87 | 88.16 | 58.98 | 105.94 | 103.53 | |
| Net Profit/Share (Rs.) | 73.43 | 64.60 | 46.54 | 83.01 | 75.20 | |
| NP After MI And SOA / Share (Rs.) | 73.43 | 64.60 | 46.54 | 83.01 | 75.20 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 29.13 | 29.85 | 23.56 | 31.27 | 35.45 | |
| PBIT Margin (%) | 26.02 | 26.63 | 20.06 | 27.52 | 31.43 | |
| PBT Margin (%) | 25.58 | 26.46 | 19.91 | 27.22 | 31.15 | |
| Net Profit Margin (%) | 19.80 | 19.39 | 15.71 | 21.33 | 22.62 | |
| NP After MI And SOA Margin (%) | 19.80 | 19.39 | 15.71 | 21.33 | 22.62 | |
| Return on Networth/Equity (%) | 24.28 | 22.87 | 17.35 | 21.83 | 21.82 | |
| Return on Capital Employed (%) | 30.10 | 29.95 | 21.21 | 26.98 | 29.02 | |
| Return on Assets (%) | 18.35 | 17.59 | 12.56 | 17.57 | 17.30 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 0.96 | 0.90 | 0.82 | 0.83 | 0.79 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.85 | 3.05 | 2.49 | 3.50 | 3.13 | |
| Quick Ratio (X) | 1.95 | 2.12 | 1.77 | 2.28 | 1.94 | |
| Inventory Turnover Ratio (X) | 5.37 | 1.14 | 1.19 | 1.10 | 1.25 | |
| Dividend Payout Ratio (NP) (%) | 38.00 | 78.68 | 15.25 | 11.53 | 12.67 | |
| Dividend Payout Ratio (CP) (%) | 32.85 | 67.48 | 12.47 | 9.81 | 10.76 | |
| Earnings Retention Ratio (%) | 62.00 | 21.32 | 84.75 | 88.47 | 87.33 | |
| Cash Earnings Retention Ratio (%) | 67.15 | 32.52 | 87.53 | 90.19 | 89.24 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 65.32 | 174.28 | 151.01 | 102.45 | 123.89 | |
| Interest Coverage Ratios (Post Tax) (%) | 65.32 | 174.28 | 151.01 | 102.45 | 123.89 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 32,649.25 | 28,149.11 | 14,945.61 | 15,321.67 | 15,384.30 | |
| EV/Net Operating Revenue (X) | 7.02 | 6.69 | 3.99 | 4.59 | 5.32 | |
| EV/EBITDA (X) | 24.11 | 22.40 | 16.95 | 14.66 | 15.02 | |
| MarketCap/Net Operating Revenue (X) | 7.06 | 6.72 | 4.08 | 4.65 | 5.40 | |
| Retention Ratios (%) | 61.99 | 21.31 | 84.74 | 88.46 | 87.32 | |
| Price/BV (X) | 8.66 | 7.93 | 4.51 | 4.76 | 5.21 | |
| Price/Net Operating Revenue | 7.06 | 6.72 | 4.08 | 4.65 | 5.40 | |
| Earnings Yield | 0.03 | 0.03 | 0.04 | 0.05 | 0.04 |
11.11.2025
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
12.07.2023
Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang
13.07.2022
Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct
11.01.2019
Ajanta Pharma Q3 PAT may dip 35.1% YoY to Rs. 95.8 cr: ICICI Direct
12.10.2018
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct